Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

Detalles Bibliográficos
Autores principales: Douxfils, Jonathan, Foidart, Jean-Michel, Gaspard, Ulysse, Chatel, Guillaume, Taziaux, Mélanie, Jost, Maud, Gérard, Céline, Morimont, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477764/
https://www.ncbi.nlm.nih.gov/pubmed/37674929
http://dx.doi.org/10.5114/pm.2023.128815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477764/
https://www.ncbi.nlm.nih.gov/pubmed/37674929
http://dx.doi.org/10.5114/pm.2023.128815

Ejemplares similares